TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12653872

Group type: EXPERIMENTAL
Intervention: Multiple risk factor intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Echogenic plaques intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: Echogenic plaques usual care
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: No plaques intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: No plaques usual care
Number of subjects: 32
Study: 11083272

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Sulfasalazine
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: High-dose penicillamine
Number of subjects: 248

Group type: COMPARATOR
Intervention: Low-dose penicillamine
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo (for minocycline)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo (for sulfasalazine)
Number of subjects: 248
Study: 8653991

Group type: EXPERIMENTAL
Intervention: Caffeine metabolite ratio AAMU + 1U + 1X/17U
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Other caffeine metabolite ratios
Number of subjects: 21
Study: 1598960

Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 10
Study: 6398982

Group type: EXPERIMENTAL
Intervention: Guar gum (21 g per day, taken with meals three times a day)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Guar gum
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 30539193

Group type: EXPERIMENTAL
Intervention: Health check and lifestyle intervention
Number of subjects: 11483

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 11483
Study: 29471158

Group type: EXPERIMENTAL
Intervention: Road traffic injuries (RTI)
Number of subjects: 13765

Group type: EXPERIMENTAL
Intervention: Healthcare seeking behavior
Number of subjects: 13765

Group type: EXPERIMENTAL
Intervention: Major procedures
Number of subjects: 13765

Group type: EXPERIMENTAL
Intervention: Major disability
Number of subjects: 13765
Study: 26953023

Group type: EXPERIMENTAL
Intervention: Anterior chamber Artisan IOL implantation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Retropupillary Artisan IOL implantation
Number of subjects: 40
Study: 25345628

Group type: EXPERIMENTAL
Intervention: Perampanel (PER) 4 mg/day
Number of subjects: 1478

Group type: EXPERIMENTAL
Intervention: Perampanel (PER) 8 mg/day
Number of subjects: 1478

Group type: EXPERIMENTAL
Intervention: Perampanel (PER) 12 mg/day
Number of subjects: 1478

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1478

Group type: EXPERIMENTAL
Intervention: Perampanel (PER) long-term treatment (10 or 12 mg/day)
Number of subjects: 1478

Group type: EXPERIMENTAL
Intervention: Adverse events (AEs) with any dose of PER
Number of subjects: 1478
Study: 22889651

Group type: EXPERIMENTAL
Intervention: Star Excursion Balance Test (SEBT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Y Balance Test (YBT)
Number of subjects: 20
Study: 20620267

Group type: EXPERIMENTAL
Intervention: Risperidone (1mg/day to 6mg/day)
Number of subjects: 26
Study: 17631904

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate, high-protein diet
Number of subjects: 32

Group type: COMPARATOR
Intervention: Low-fat control diet
Number of subjects: 32
Study: 16599033

Group type: EXPERIMENTAL
Intervention: Metoclopramide 0.1‐0.2 mg kg(‐1)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Prochlorperazine 0.1‐0.2 mg kg(‐1)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo (5% Dextrose and normal saline 2ml)
Number of subjects: 150
Study: 12374446

Group type: EXPERIMENTAL
Intervention: Sad mood condition with cognitive load task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Induced sadness
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sad participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Higher Beck Depression Inventory scores
Number of subjects: 0
Study: 9929022

Group type: EXPERIMENTAL
Intervention: L-NMMA (6 mg/kg intravenous infusion)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: L-NMMA
Number of subjects: 16
Study: 7478254

Group type: EXPERIMENTAL
Intervention: Tetrahydroaminoacridine (THA) 75 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tetrahydroaminoacridine (THA) 25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tetrahydroaminoacridine (THA) 25 or 75 mg
Number of subjects: 0
Study: 2123433

Group type: EXPERIMENTAL
Intervention: Cerebrolysin plus multi-vitamins infusions
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (multi-vitamins alone)
Number of subjects: 41
Study: 6966331

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 132

Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 132
Study: 31808248

Group type: EXPERIMENTAL
Intervention: Standard care plus commercial weight management sessions commencing 8-16 weeks postnatally
Number of subjects: 193

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 193
Study: 30772006

Group type: EXPERIMENTAL
Intervention: Laparoscopic gastrectomy
Number of subjects: 317

Group type: COMPARATOR
Intervention: Open gastrectomy
Number of subjects: 317
Study: 28081673

Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir plus lamivudine (dual therapy)
Number of subjects: 44

Group type: COMPARATOR
Intervention: lopinavir/ritonavir plus 2 NRTI (triple therapy)
Number of subjects: 44
Study: 25882763

Group type: EXPERIMENTAL
Intervention: ziprasidone
Number of subjects: 49

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 49
Study: 24066805

Group type: EXPERIMENTAL
Intervention: Psychodynamic Motivation and Training program (PMT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: One session of advice in exercise training (EX)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 90
Study: 21848443

Group type: EXPERIMENTAL
Intervention: X(A) - progressive high-intensity exercise (≥ 75% maximum heart rate) with nutrition and parent education sessions
Number of subjects: 27

Group type: COMPARATOR
Intervention: O(B) - control group
Number of subjects: 27
Study: 19480863

Group type: EXPERIMENTAL
Intervention: Weight-bearing (WB) exercise
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Nonweight-bearing (NWB) exercise
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 106
Study: 17252032

Group type: EXPERIMENTAL
Intervention: National Upper Cervical Chiropractic (NUCCA) procedure
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham procedure (placebo)
Number of subjects: 50
Study: 15131536

Group type: EXPERIMENTAL
Intervention: Stent placement
Number of subjects: 10347

Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 10347
Study: 11359763

Group type: EXPERIMENTAL
Intervention: Nicorandil (20 mg twice daily)
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5000

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 5000
Study: 9424198

Group type: EXPERIMENTAL
Intervention: Single dose of phytoadaptogen (Adapt)
Number of subjects: 5
Study: 8221501

Group type: EXPERIMENTAL
Intervention: Meeting a person with AIDS in the classroom (treatment group)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Comparison group (no meeting with a person with AIDS)
Number of subjects: 4
Study: 3624149

Group type: EXPERIMENTAL
Intervention: Theophylline (T)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Enprofylline (E)
Number of subjects: 10
Study: 31580698

Group type: EXPERIMENTAL
Intervention: Resistive Tecar Therapy (TT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Capacitive Tecar Therapy (TT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29392530

Group type: EXPERIMENTAL
Intervention: LANAP
Number of subjects: 15

Group type: COMPARATOR
Intervention: ENAP
Number of subjects: 15
Study: 27124042

Group type: EXPERIMENTAL
Intervention: Interferon gamma release assay (IGRA)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tuberculin skin test (TST)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Comparison of IGRA and TST
Number of subjects: 150
Study: 25344693

Group type: EXPERIMENTAL
Intervention: AHP-SF (short-form Adolescent Health Promotion Scale)
Number of subjects: 814

Group type: EXPERIMENTAL
Intervention: AHP-SF
Number of subjects: 814
Study: 23216418

Group type: EXPERIMENTAL
Intervention: Behaviour stories
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Communication stories
Number of subjects: 20
Study: 20395973

Group type: EXPERIMENTAL
Intervention: DisCoVisc
Number of subjects: 323

Group type: COMPARATOR
Intervention: Healon5
Number of subjects: 323
Study: 18925430

Group type: EXPERIMENTAL
Intervention: Recombinant HCG (rHCG) - 250 microg subcutaneous injection
Number of subjects: 89

Group type: COMPARATOR
Intervention: Urinary HCG (uHCG) - 10,000 IU intramuscular injection
Number of subjects: 89
Study: 15672335

Group type: EXPERIMENTAL
Intervention: 0.25 microg/kg naloxone
Number of subjects: 131

Group type: COMPARATOR
Intervention: 0.10 mg/kg morphine IV bolus
Number of subjects: 131
Study: 12938130

Group type: EXPERIMENTAL
Intervention: 0.05 T
Number of subjects: 25

Group type: COMPARATOR
Intervention: 8 T
Number of subjects: 25
Study: 10497374

Group type: EXPERIMENTAL
Intervention: Flutter valve
Number of subjects: 23

Group type: COMPARATOR
Intervention: CPT
Number of subjects: 23
Study: 8759532

Group type: EXPERIMENTAL
Intervention: Otovent treatment set
Number of subjects: 0

Group type: COMPARATOR
Intervention: Valsalva manoeuvre
Number of subjects: 0
Study: 2012010

Group type: EXPERIMENTAL
Intervention: 200 mg palmvitee capsules/day
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 200 mg gamma-tocotrienol/d
Number of subjects: 15

Group type: COMPARATOR
Intervention: 300 mg corn oil/d
Number of subjects: 15
Study: 7081191

Group type: EXPERIMENTAL
Intervention: Cimetidine treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 0
Study: 6428260

Group type: EXPERIMENTAL
Intervention: PEEP/CPAP
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: PEEP/O2-catheter
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: ZEEP/CPAP
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: ZEEP/O2-catheter
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Intra- and post-operative increase in airway pressure
Number of subjects: 64
Study: 29289383

Group type: EXPERIMENTAL
Intervention: HBsAg-1018 (HEPLISAV-B™) administered intramuscularly at weeks 0 and 4
Number of subjects: 8374

Group type: COMPARATOR
Intervention: HBsAg-Eng (Engerix-B®) administered at weeks 0, 4, and 24
Number of subjects: 8374

Group type: EXPERIMENTAL
Intervention: HBsAg-1018 (HEPLISAV-B™) in total study population (N=6826)
Number of subjects: 8374

Group type: COMPARATOR
Intervention: HBsAg-Eng (Engerix-B®) in total study population (N=6826)
Number of subjects: 8374
Study: 26968277

Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (5.6 g/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Oral paraffin (placebo)
Number of subjects: 23
Study: 24504775

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention
Number of subjects: 131
Study: 22228325

Group type: EXPERIMENTAL
Intervention: Tracheal/esophageal traction exercise (TTE) treatment for 3 consecutive days before surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no TTE treatment)
Number of subjects: 0
Study: 19306024

Group type: EXPERIMENTAL
Intervention: Myrtle oral paste applied four times a day for 6 days
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo paste
Number of subjects: 45
Study: 18366729

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Analysis System of Psychotherapy (CBASP) in combination with medication
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual secondary care in combination with medication
Number of subjects: 160
Study: 16113617

Group type: EXPERIMENTAL
Intervention: TAU SSRI plus brief cognitive-behavioral therapy (CBT) (n = 77)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) control condition (n = 75)
Number of subjects: 152
Study: 12455393

Group type: EXPERIMENTAL
Intervention: Mycobacterium w plus HAART
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Mycobacterium w alone
Number of subjects: 50

Group type: COMPARATOR
Intervention: Mycobacterium w plus two antiretroviral agents
Number of subjects: 50
Study: 10521835

Group type: EXPERIMENTAL
Intervention: Early amniocentesis (11 + 0‐14 + 6 weeks)
Number of subjects: 2924

Group type: EXPERIMENTAL
Intervention: Traditional mid‐trimester amniocentesis (15 + 0‐18 + 6 weeks)
Number of subjects: 2924

Group type: EXPERIMENTAL
Intervention: Amniocentesis after 18 + 6 weeks' gestation
Number of subjects: 2924

Group type: EXPERIMENTAL
Intervention: Cumulative miscarriage risk after early amniocentesis
Number of subjects: 2924

Group type: EXPERIMENTAL
Intervention: Early amniocentesis
Number of subjects: 2924

Group type: EXPERIMENTAL
Intervention: Traditional mid‐trimester amniocentesis
Number of subjects: 2924

Group type: EXPERIMENTAL
Intervention: Amniocentesis after 19 weeks' gestation
Number of subjects: 2924
Study: 7793224

Group type: EXPERIMENTAL
Intervention: Alfentanil 30 micrograms kg‐1
Number of subjects: 24

Group type: COMPARATOR
Intervention: Physiologic saline (Control)
Number of subjects: 24
Study: 2029855

Group type: EXPERIMENTAL
Intervention: Transcranial electric treatment (TET) with constant current and pulse current of square impulses of 70-80 Hz
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 7332089

Group type: EXPERIMENTAL
Intervention: Tramadol-HCl continuous infusion
Number of subjects: 0
Study: 31283989

Group type: EXPERIMENTAL
Intervention: Active transcranial direct current stimulation (tDCS)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 14
Study: 30124459

Group type: EXPERIMENTAL
Intervention: Robot-assisted therapy (30 min per session, 5 sessions per week for 8 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: General occupational therapy (30 min per session, 5 sessions per week for 8 weeks)
Number of subjects: 30
Study: 26914592

Group type: EXPERIMENTAL
Intervention: Auto-titrating CPAP (n=122)
Number of subjects: 244

Group type: COMPARATOR
Intervention: No positive airway pressure (n=122)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: CPAP usage for ≥4 hours per night
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: CPAP usage for <4 hours per night or no treatment
Number of subjects: 244
Study: 24532004

Group type: EXPERIMENTAL
Intervention: Unloader knee orthosis
Number of subjects: 7
Study: 22309059

Group type: EXPERIMENTAL
Intervention: Integrated presentation (Experiments 1 and 3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integrated-with-labels presentation (Experiment 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integrated groups (Experiments 1 and 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Separated groups (Experiments 1 and 2)
Number of subjects: 0
Study: 20236911

Group type: EXPERIMENTAL
Intervention: Quartz‐tungstenhalogen (QTH) curing unit (400 mW/cm2) for 20 seconds
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Quartz‐tungstenhalogen (QTH) curing unit (400 mW/cm2) for 40 seconds
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Light‐emitting‐diode (LED) curing unit (180 mW/cm2) for 20 seconds
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Light‐emitting‐diode (LED) curing unit (180 mW/cm2) for 40 seconds
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ethanol storage for 24 hours
Number of subjects: 40
Study: 17317364

Group type: EXPERIMENTAL
Intervention: Q-wave myocardial infarction (MI)
Number of subjects: 1221

Group type: EXPERIMENTAL
Intervention: Conduction abnormalities
Number of subjects: 1221

Group type: COMPARATOR
Intervention: Non-Q-wave MI
Number of subjects: 1221
Study: 15674491

Group type: EXPERIMENTAL
Intervention: Transverse incision laparotomy
Number of subjects: 94

Group type: COMPARATOR
Intervention: Midline incision laparotomy
Number of subjects: 94
Study: 11888402

Group type: EXPERIMENTAL
Intervention: Bonus financial incentive
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Enhanced fee-for-service financial incentive
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Bonus group (immunizations given by others)
Number of subjects: 50
Study: 9596431

Group type: EXPERIMENTAL
Intervention: Nebulized glucagon (2 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nebulized saline (placebo)
Number of subjects: 10
Study: 7946899

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 micrograms/d for 8 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3042994

Group type: EXPERIMENTAL
Intervention: Intravenous regular insulin (0.0, 0.5, 1.0, 2.0, 3.0, and 4.0 units)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intravenous regular insulin (various doses)
Number of subjects: 6
Study: 30836228

Group type: EXPERIMENTAL
Intervention: ELLIPTA
Number of subjects: 0

Group type: COMPARATOR
Intervention: MDI-1
Number of subjects: 0

Group type: COMPARATOR
Intervention: MDI-2
Number of subjects: 0

Group type: COMPARATOR
Intervention: MDI
Number of subjects: 0
Study: 28619274

Group type: EXPERIMENTAL
Intervention: Presentation of Modified Dental Anxiety Scale (MDAS) score sheet to the dentist
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presentation of MDAS to the dentist with open response to patient fears
Number of subjects: 0
Study: 26349115

Group type: EXPERIMENTAL
Intervention: Garenoxacin 200 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Garenoxacin 400 mg
Number of subjects: 20
Study: 23131836

Group type: EXPERIMENTAL
Intervention: Video-assisted swallowing therapy (VAST)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 42
Study: 21905793

Group type: EXPERIMENTAL
Intervention: TachoComb
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (no hemostatic agents)
Number of subjects: 120
Study: 18809272

Group type: EXPERIMENTAL
Intervention: Digital Subtraction Angiography (DSA)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 3D time‐of‐flight MR angiography (TOF‐MRA) at 3 Tesla (3T)
Number of subjects: 51
Study: 17932102

Group type: EXPERIMENTAL
Intervention: Primary percutaneous coronary intervention (PCI)
Number of subjects: 1522

Group type: COMPARATOR
Intervention: Fibrinolytic therapy (FT)
Number of subjects: 1522

Group type: EXPERIMENTAL
Intervention: EMI group overall
Number of subjects: 1522

Group type: EXPERIMENTAL
Intervention: EMI group with anterior EMI without ECG signs of reperfusion
Number of subjects: 1522
Study: 15129929

Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (CHO)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High fat diet (FAT)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High fat diet combined with training (FAT+T)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High carbohydrate diet combined with training (CHO+T)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Both groups (CHO+T and FAT+T)
Number of subjects: 8
Study: 11826486

Group type: EXPERIMENTAL
Intervention: Aranoza
Number of subjects: 0
Study: 9214140

Group type: EXPERIMENTAL
Intervention: Various carbohydrate-containing products
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Traditional Russian food and dishes
Number of subjects: 0
Study: 8225637

Group type: EXPERIMENTAL
Intervention: Clarithromycin (125 mg for <25 kg or 250 mg for >25 kg, twice daily for 5 days)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Amoxycillin (125 mg for <25 kg or 250 mg for >25 kg, three times daily for 5 days)
Number of subjects: 259
Study: 2871241

Group type: EXPERIMENTAL
Intervention: MMR vaccine
Number of subjects: 1162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1162
Study: 31584149

Group type: EXPERIMENTAL
Intervention: Telephone-Based Chaplaincy Intervention
Number of subjects: 23

Group type: COMPARATOR
Intervention: Attention-Control Condition
Number of subjects: 23
Study: 30579352

Group type: EXPERIMENTAL
Intervention: Anteromedial portal method
Number of subjects: 104

Group type: COMPARATOR
Intervention: Transtibial method
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 104
Study: 27178892

Group type: EXPERIMENTAL
Intervention: Kids nasal strips
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Regular nasal strips
Number of subjects: 40
Study: 24321619

Group type: EXPERIMENTAL
Intervention: Decompressive surgery
Number of subjects: 95

Group type: COMPARATOR
Intervention: Local corticosteroid injection
Number of subjects: 95
Study: 22957034

Group type: EXPERIMENTAL
Intervention: SMS text messages (n = 600)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Usual care (n = 600)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: SMS text messages
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Men paying > US$1.25 for travel
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Men with secondary or higher education
Number of subjects: 1200
Study: 20140447

Group type: EXPERIMENTAL
Intervention: SDEP (Sleep Deprivation)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: SDEP + ER (Sleep Deprivation + Energy Restriction)
Number of subjects: 10

Group type: COMPARATOR
Intervention: CON (Control)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Modest whole-body cooling
Number of subjects: 10
Study: 18657676

Group type: EXPERIMENTAL
Intervention: Primary angioplasty
Number of subjects: 1572

Group type: COMPARATOR
Intervention: Fibrinolysis
Number of subjects: 1572
Study: 15811487

Group type: EXPERIMENTAL
Intervention: Patient clinical trials handbook (experimental group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no handbook)
Number of subjects: 90
Study: 12618501

Group type: COMPARATOR
Intervention: Vinorelbine (30 mg/m²)
Number of subjects: 698

Group type: COMPARATOR
Intervention: Gemcitabine (1200 mg/m²)
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: Vinorelbine (25 mg/m²) plus Gemcitabine (1000 mg/m²)
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: Quality of life across all treatment arms
Number of subjects: 698
Study: 10588229

Group type: EXPERIMENTAL
Intervention: Dexfen
Number of subjects: 941

Group type: EXPERIMENTAL
Intervention: Dexfen SR
Number of subjects: 941

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 941

Group type: EXPERIMENTAL
Intervention: Combined Dexfen groups
Number of subjects: 941